Takhzyro (lanadelumab-flyo) Approval with Humana in New York: Answers to the Most Common Questions
Answer Box: Getting Takhzyro Covered by Humana in New York
Takhzyro (lanadelumab-flyo) requires prior authorization from Humana for hereditary angioedema (HAE) prophylaxis. You'll need confirmed HAE type I/II diagnosis with lab documentation, specialist prescriber, and evidence of prior therapy failures. If denied, New York residents can file